Sienna Biopharmaceuticals, Inc.
OTC: SNNAQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- David E. I. Pyott
- Employees
- 13
- Headquarters
- Westlake Village, United States
- IPO year
- 2017
- Market cap
- $3.1K
- Website
- https://www.siennabio.com
Loading SNNAQ…
Loading profile data…Frequently asked questions about SNNAQ
What does Sienna Biopharmaceuticals, Inc. (SNNAQ) do?
Sienna Biopharmaceuticals, Inc. was a clinical-stage biopharmaceutical firm dedicated to discovering and advancing pharmaceutical treatments across diverse therapeutic fields. Its primary focus involved crafting therapies within immunology and inflammation, specifically targeting particular tissue pathways, notably in the skin. Among its pipelin...
Where does SNNAQ trade?
Sienna Biopharmaceuticals, Inc. (SNNAQ) trades on the Other OTC.
What sector is SNNAQ in?
Sienna Biopharmaceuticals, Inc. (SNNAQ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sienna Biopharmaceuticals, Inc.?
David E. I. Pyott is the chief executive officer of Sienna Biopharmaceuticals, Inc. (SNNAQ).
Where is Sienna Biopharmaceuticals, Inc. headquartered?
Sienna Biopharmaceuticals, Inc. is headquartered in United States.
Does SNNAQ pay a dividend?
Sienna Biopharmaceuticals, Inc. (SNNAQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SNNAQ go public?
Sienna Biopharmaceuticals, Inc. (SNNAQ) completed its initial public offering in 2017.